25 sub-sectors across 5 groups. India's ₹25L Cr+ healthcare economy mapped — from pharma manufacturing to AI diagnostics, clinical research to hospital chains.
25
Sub-Sectors
5
Sector Groups
150
Hot Roles Mapped
12%
CAGR Growth
What This Guide Covers
Pharma and healthcare are among the most domain-specific recruiting environments. An MR is not an MSL. A pharma quality head is not a medical device quality head. A hospital COO is not a healthtech COO. This guide decodes every sub-sector, maps the talent dynamics, and gives you the intelligence to avoid the most costly mis-hires in this high-stakes industry.
🌏 Sector Map
All 25 sub-sectors with business model, key companies, hot roles, and recruiter intelligence.
🏭 The Landscape
India's pharma & health market, key regulations (CDSCO, ABDM, GMP), and talent archetypes.
🔍 Hiring Intelligence
Hardest roles to fill, what great looks like, and screening questions by track.
🏆 Role Deep Dives
Branded generics vs export pharma vs hospital vs healthtech — talent portability mapped.
📈 Compensation
MR to NSM, MSL to Medical Director, hospital CEO, CRO head — India pay benchmarks.
📋 Practitioner Lab
Six real scenarios — MR for MSL, ANDA gap, hospital CEO from hospitality. Plus jargon decoded.
The 5 Sector Groups
Pharmaceutical Companies
5 sub-sectors — India: the pharmacy of the world
Medical Devices & Diagnostics
5 sub-sectors — The hardware and testing of healthcare
Hospital & Healthcare Delivery
5 sub-sectors — Where patients receive care at scale
Digital Health & HealthTech
5 sub-sectors — Technology meeting healthcare
Clinical Research & Life Sciences
5 sub-sectors — The science that creates new medicines
The India Pharma & Healthcare Sector Map
25 sub-sectors across 5 groups. Click any card to explore business model, companies, hot roles & recruiter intelligence.
🔍
1
Pharmaceutical Companies
India: the pharmacy of the world
5 sectors
1💊
Large Indian Pharma (Branded Generics)
Sun Pharma, Cipla, Dr. Reddy's — branded generics for India and generic exports globally. Dual business model.
6 roles
2🧪
API & Bulk Drug Manufacturing
India supplies 20% of global API. Hyderabad's Pharma City is the epicentre.
6 roles
3🌐
Generic Drug Export (ANDA/US Market)
Filing ANDAs, winning FDA approvals, competing in the world's largest generic drug market.
ICON, Parexel, Syneos, Syngene — running clinical trials for global pharma. India is a preferred CRO destination.
6 roles
22⚗️
Clinical Trials (Phase I-IV)
India's large diverse population and lower costs make it a preferred clinical trial location.
6 roles
23📋
Regulatory Affairs (Pharma & Devices)
Filing dossiers with CDSCO, FDA, EMA. The gatekeeper between development and market. Thin talent pool.
6 roles
24🔍
Pharmacovigilance & Drug Safety
Monitoring adverse drug reactions post-launch. Mandatory for all marketed drugs globally.
6 roles
25👨⚕️
Medical Affairs & Medical Science Liaisons (MSL)
Scientific bridge between pharma companies and medical community. Requires clinical + commercial understanding.
6 roles
Business Model
India market (branded generics: same molecule, brand name, doctor prescription-driven) and export market (unbranded generics filed via ANDA in US, dossier in EU). India market = margin; export = volume. Top 3 Indian pharma companies are in global top 25 by revenue.
Large pharma has two very different career tracks: commercial (MR→RSM→NSM→VP Sales) and technical (plant ops, quality, regulatory affairs). These don't interchange well at senior levels. Red flag: commercial pharma candidates for regulatory affairs or plant head roles — very different competencies.
🚫 Red Flags
⚠️ Commercial/sales pharma candidates for technical roles (QA, regulatory, manufacturing)
⚠️ Generic drug company candidates for innovator pharma roles without clinical trial experience
⚠️ MR-track candidates for hospital sales or institution sales roles — different buyer, different selling approach
Business Model
Active Pharmaceutical Ingredients (API) manufacturing: the chemical synthesis of drug molecules before formulation. Revenue: per-kg pricing to pharma companies globally. Margins: 20-35% EBITDA for specialty APIs. India is the world's largest producer of generic APIs — a critical global supply chain node.
API manufacturing requires chemical engineering and process chemistry depth — different from formulations. Red flag: formulations plant heads for API plant roles — chemical synthesis processes are fundamentally different from tablet/capsule manufacturing.
🚫 Red Flags
⚠️ Formulation plant heads for API manufacturing roles without chemical synthesis process experience
⚠️ Quality candidates without API-specific GMP knowledge (ICH Q7)
⚠️ R&D candidates without process scale-up experience (kilo lab to pilot to commercial scale)
Business Model
US generic drug market: file ANDA with US FDA, get approval, manufacture in GMP-compliant plant, sell to US wholesalers/pharmacies. Revenue: market share of specific drug molecules post-patent expiry. First-to-file ANDA gets 180-day market exclusivity — massive value. India's pharma companies have 300+ ANDA filings pending at any time.
Key India Companies
Dr. Reddy's Laboratories (US generics)
Aurobindo Pharma (US focus)
Lupin (US generics)
Sun Pharma (US specialty + generics)
Alkem Laboratories
Gland Pharma
Strides Pharma
Emcure Pharmaceuticals
Org Structure Signals
Regulatory Affairs (ANDA filings, FDA interactions), Manufacturing (US FDA-approved plants), Quality (FDA readiness, 483 response), R&D (generic drug development), Business Development (US market).
Hot Roles SNH Recruits
Head of Regulatory Affairs (ANDA/USFDA)
FDA Inspection Manager
US Business Development Head
R&D Head (Generic Drug Development)
Manufacturing Head (US FDA plant)
QA Head (USFDA compliance)
🔍 Recruiter Intelligence
US generic pharma requires specific regulatory expertise — ANDA filing, FDA inspection management, and 483/Warning Letter response. One FDA Warning Letter can shut a plant. Red flag: candidates who've 'supported' FDA inspections without owning the inspection response.
🚫 Red Flags
⚠️ Regulatory candidates without ANDA filing experience claiming 'regulatory affairs' depth
⚠️ Manufacturing heads without US FDA plant audit experience for US-export pharma roles
⚠️ QA candidates without experience writing 483 responses and CAPA documentation for FDA
Business Model
Consumer health products sold over-the-counter (no prescription needed). Includes: OTC drugs (Crocin, Vicks), Ayurvedic products (Chyawanprash, hair oils), nutraceuticals, and personal care (Health products). Revenue: retail push, advertising spend, doctor recommendation. Much closer to FMCG than pharma in talent requirement.
Key India Companies
Dabur India
Himalaya Drug Company
Zydus Wellness
Emami Limited
Hamdard India
Baidyanath Group
Patanjali Ayurved
Cipla OTC (EldoSun, Nicotex)
Org Structure Signals
Marketing (brand management, advertising), Sales (GT/MT), Manufacturing (FMCG-style, but with Schedule M compliance), R&D (Ayurvedic formulation, clinical validation), Regulatory (AYUSH licensing).
Hot Roles SNH Recruits
Brand Manager (OTC)
National Sales Head (Consumer Health)
Category Head (OTC/Nutraceuticals)
R&D Head (Ayurvedic/Nutraceuticals)
Regulatory Affairs Manager (AYUSH)
Marketing Head
🔍 Recruiter Intelligence
OTC/consumer health is much closer to FMCG than pharma. Marketing-led businesses value brand management and consumer insight over regulatory depth. Red flag: purely prescription pharma sales candidates for OTC brand management roles — different channel, different buyer, different marketing approach.
🚫 Red Flags
⚠️ Prescription pharma sales candidates for OTC marketing roles without consumer brand understanding
⚠️ FMCG candidates for AYUSH regulatory affairs roles without Ayurvedic regulatory knowledge
⚠️ R&D candidates from conventional pharma without traditional medicine or nutraceutical formulation experience
Business Model
Biologics manufacturing: large molecule drugs produced through living cells. Vaccines, monoclonal antibodies, biosimilars. Revenue: global supply contracts (Serum Institute is the world's largest vaccine manufacturer). Manufacturing complexity is extreme — cell culture, fermentation, purification, fill-finish.
Key India Companies
Serum Institute of India
Biocon Limited
Dr. Reddy's Biologics
Biological E
Bharat Biotech
Indian Immunologicals
Panacea Biotec
Cipla Biologics
Org Structure Signals
Process Development (cell culture, upstream/downstream), Manufacturing (bioreactor, purification), Quality (QA/QC for biologics), Regulatory (BLA filings, WHO PQ), R&D (new biologics development).
Hot Roles SNH Recruits
Bioprocess Engineer / Head
Manufacturing Head (Biologics)
QA Head (Biologics — GMP)
Regulatory Affairs Head (BLA/WHO PQ)
R&D Head (Biologics)
VP Manufacturing (Vaccines)
🔍 Recruiter Intelligence
Biologics manufacturing requires specific bioreactor and downstream purification expertise — very different from small molecule (API/formulation) manufacturing. Red flag: small molecule pharma manufacturing candidates for biologics roles without bioreactor or cell culture experience.
🚫 Red Flags
⚠️ Small molecule (API/formulation) manufacturing heads for biologics plant roles without cell culture experience
⚠️ R&D candidates without protein chemistry or monoclonal antibody development background
Business Model
Medical imaging: CT, MRI, X-ray, ultrasound. Revenue: equipment sale + annual maintenance contracts (AMC) + upgrades. AMC revenue is high-margin and recurring. Capital selling to hospitals — long sales cycles (6-18 months), committee decisions. GE and Siemens have significant India manufacturing for export.
Key India Companies
GE Healthcare India
Siemens Healthineers India
Philips India
Carestream
Canon Medical India
Mindray India
Wipro GE Healthcare
Allengers Medical Systems
Org Structure Signals
Sales (hospital key accounts), Service (installation, maintenance engineers), Applications (clinical training), Manufacturing (for some), R&D (India centres of GE/Siemens).
Hot Roles SNH Recruits
Sales Head (Radiology / Imaging)
Hospital Key Account Manager
Service Head (Medical Equipment)
Applications Specialist
Country Head (Medical Devices)
Business Development Head
🔍 Recruiter Intelligence
Medical imaging sales requires both clinical understanding (radiology, pathology) and hospital procurement process knowledge. Red flag: general capital equipment sales candidates without clinical/healthcare institutional sales experience.
🚫 Red Flags
⚠️ Capital equipment sales candidates from non-healthcare without clinical application understanding
⚠️ Service heads without multi-location biomedical engineering team management
⚠️ Sales candidates without hospital C-suite engagement experience (CFO, Medical Director, COO)
Business Model
IVD: diagnostic tests performed on blood, urine, tissue samples outside the body. Revenue: reagent kits (recurring, high margin) + analyzer equipment. B2B selling to hospitals, diagnostic labs, government health programmes. COVID created massive demand for PCR kits and rapid antigen tests.
IVD requires specific regulatory knowledge (CDSCO IVD regulations, 2017 Medical Devices Rules). Red flag: pharma regulatory candidates for IVD regulatory roles without understanding of IVD-specific dossier requirements.
🚫 Red Flags
⚠️ Pharma regulatory candidates for IVD regulatory roles — different dossier structure and testing requirements
⚠️ R&D candidates without assay development and validation experience
Business Model
Surgical instruments: reusable and disposable tools for surgery. Implants: hip, knee, spine, trauma implants placed inside the body. Revenue: B2B to hospitals + surgeon preference (implant selection is surgeon-driven). India exports significant volumes of basic surgical instruments to global markets.
Key India Companies
Poly Medicure
Nasan Medical Industries
Hindustan Syringes
Sutures India
Sahajanand Medical Technologies
Meril Life Sciences
Smith & Nephew India
Stryker India
Org Structure Signals
Manufacturing (precision machining, biocompatible materials), Regulatory (ISO 13485, CDSCO implant registration), Sales (hospital + surgeon relationship), Quality (ISO 13485).
Hot Roles SNH Recruits
Orthopaedic Sales Head (Implants)
Manufacturing Head (Surgical Instruments)
Quality Head (ISO 13485)
Regulatory Affairs Head (Class III Implants)
Hospital Key Account Manager
Surgeon Training Head
🔍 Recruiter Intelligence
Implant sales requires intimate knowledge of surgical procedures and surgeon relationships. A knee implant sales person must be comfortable in the operating theatre. Red flag: pharma or general medical device sales candidates without implant-specific surgical case coverage experience.
🚫 Red Flags
⚠️ General medical device sales candidates for implant/surgical sales without OR (operating room) experience
⚠️ Quality candidates without ISO 13485 and risk management (ISO 14971) experience for Class III implant roles
⚠️ Regulatory candidates without Class III device dossier preparation experience
Business Model
Indian medical device startups: developing novel devices for Indian and global markets. Revenue: early revenue from Indian hospital sales + global expansion + grants (BIRAC). CDSCO regulatory pathway for Class II and III devices takes 1-2 years — a major bottleneck. India has <5% global share of medical device manufacturing.
Medical device startups need regulatory and clinical validation experience that is extremely scarce in India. Red flag: pharma regulatory candidates for medical device startups without device-specific clinical validation methodology experience.
🚫 Red Flags
⚠️ Pharma regulatory candidates for medical device regulatory roles without device testing standard knowledge (IEC 60601, ISO 14971)
⚠️ Clinical affairs candidates without clinical trial management experience in regulated environments
⚠️ Manufacturing candidates without design controls and V&V testing experience for device development
Business Model
Devices for self-monitoring at home or point-of-care (clinic, pharmacy). Revenue: consumer retail + B2B (hospital, pharmacy). High volume, lower per-unit value. Connected health devices (Bluetooth-enabled glucometers, smartwatches with health sensors) are the growth frontier.
Home healthcare devices blend consumer electronics and medical device cultures. Red flag: pure medical device candidates without consumer product marketing or e-commerce distribution experience for retail health device brands.
🚫 Red Flags
⚠️ Pure medical device candidates without consumer marketing or retail distribution experience
⚠️ FMCG marketing candidates without understanding of medical device regulatory requirements (CDSCO registration, class classification)
⚠️ Manufacturing candidates without medical device quality system (ISO 13485) experience
Business Model
Multi-specialty hospitals: run across 10-20+ specialties under one roof. Revenue: IP (inpatient) + OP (outpatient) + diagnostics. Apollo is India's largest hospital chain (₹16,000Cr+ revenue). Revenue per patient bed per day is the key unit economics metric. Occupancy rate and payer mix (insurance vs self-pay vs government) determine profitability.
Hospital operations is one of the most complex management roles — managing clinical staff, financial sustainability, regulatory compliance, and patient experience simultaneously. Red flag: corporate operations candidates without clinical environment experience for hospital COO roles.
🚫 Red Flags
⚠️ Corporate/FMCG operations candidates for hospital operations roles without clinical environment experience
⚠️ Finance candidates without healthcare billing (insurance, TPA management) experience
⚠️ Marketing candidates without patient acquisition and healthcare branding experience
Business Model
Single specialty: hospitals focused on one specialty (cardiac, ophthalmology, oncology, orthopaedic, maternity). Revenue: higher volume, specialty-specific pricing. Clinical excellence and protocol-driven care are competitive advantages. Narayana Health's ₹5,000 open-heart surgery is a global healthcare innovation case study.
Key India Companies
Narayana Health (cardiac)
Aravind Eye Care System
Cloudnine Hospitals (maternity)
Paras Healthcare
Care Hospitals
HCG (oncology)
Pacific Medical Centers
Vikram Hospital
Org Structure Signals
Clinical team (specialty-focused), Operations (more streamlined than multi-specialty), Business Development (referral network), Finance.
Hot Roles SNH Recruits
Hospital CEO / VP Operations
Medical Superintendent
Business Development Head (Referrals)
Operations Head
Finance Head (Hospital)
Nursing Superintendent
🔍 Recruiter Intelligence
Single specialty hospitals are more operationally focused and protocol-driven than multi-specialty. Business development means building referral networks with general practitioners and corporate health programmes. Red flag: candidates without specialty-specific clinical environment experience.
🚫 Red Flags
⚠️ Multi-specialty hospital COOs for single-specialty roles without understanding of specialty-specific clinical protocols
⚠️ Business development candidates without physician referral relationship experience
⚠️ Finance candidates without specialty-specific billing and insurance cashless management experience
Business Model
Diagnostic chains: collection centres (phlebotomy), processing labs, radiology centres. Revenue: per-test pricing, B2C (walk-in) + B2B (hospital referrals, corporate health). Thyrocare pioneered hub-and-spoke centralised testing model in India. Digital-first ordering and home collection is growing fast.
Key India Companies
Dr. Lal PathLabs
Metropolis Healthcare
Thyrocare Technologies
SRL Diagnostics
Neuberg Diagnostics
Vijaya Diagnostic Centre
Krsnaa Diagnostics
Agilus Diagnostics
Org Structure Signals
Lab Operations (testing quality), Collection Centre Network, Business Development (hospital B2B + corporate), Marketing (consumer), IT (LIMS, digital ordering).
Hot Roles SNH Recruits
Lab Operations Head
Business Development Head (Hospital B2B)
Collection Centre Network Head
Quality Head (NABL accreditation)
Digital/IT Head (LIMS)
Marketing Head (Consumer)
🔍 Recruiter Intelligence
Diagnostics is an operations + quality + distribution business. NABL accreditation is mandatory for quality labs. Red flag: healthcare sales candidates without laboratory or diagnostic chain business model understanding.
🚫 Red Flags
⚠️ Pharma sales candidates for diagnostic chain B2B roles without hospital/lab relationship experience
⚠️ Quality candidates without NABL accreditation experience for diagnostic lab quality roles
⚠️ Operations candidates without understanding of hub-and-spoke logistics for diagnostic sample transport
Business Model
Pharmacy retail: dispensing prescriptions + OTC products. Revenue: product margin + generic substitution (higher margin). Franchise model (Apollo Pharmacy) and company-owned (MedPlus) are the dominant offline models. Online pharmacy (PharmEasy, 1mg) growing but regulated — prescription drug delivery requires digital prescription verification.
Pharmacy retail requires pharmacist licensing understanding and drug dispensing regulations. Online pharmacy regulation is evolving. Red flag: retail operations candidates without pharmacy regulatory or drug dispensing knowledge.
🚫 Red Flags
⚠️ Retail operations candidates without understanding of Schedule H/H1 drug dispensing regulations
⚠️ Procurement candidates without generic drug substitution and drug purchasing economics knowledge
⚠️ Digital candidates without understanding of e-pharmacy regulation and prescription verification requirements
Business Model
Home healthcare services: skilled nursing, physiotherapy, post-operative care, elder care, and chronic disease management at home. Revenue: per-visit or per-month subscription. Operationally complex: scheduling clinical staff for home visits across cities. ABDM digital health infrastructure is creating data-sharing opportunity.
Key India Companies
Portea Medical
Nightingales Home Health Services
Care24
iCliniq (teleconsult + home care)
Medline Healthcare
Medwell
DocsApp
Lybrate
Org Structure Signals
Clinical Ops (nurse/physio scheduling), Quality (clinical care protocols), Technology (scheduling platform, EMR), Business Development (hospital discharge partnerships), Finance.
Hot Roles SNH Recruits
Clinical Operations Head
Quality Head (Home Care Protocols)
Technology Head (Scheduling Platform)
Business Development Head (Hospital Partnerships)
City Operations Head
Nursing Superintendent (Home Care)
🔍 Recruiter Intelligence
Home care is a distributed ops business — managing clinical staff in patients' homes across a city is very different from hospital ops. Red flag: hospital ops candidates without distributed field staff management experience.
🚫 Red Flags
⚠️ Hospital operations candidates for home care ops roles without field force management experience
⚠️ Clinical candidates without understanding of home care safety protocols (clinical care outside hospital setting)
⚠️ Business development candidates without hospital discharge partnership experience — the primary referral channel for home care
Business Model
Teleconsultation: video or text consultation with a doctor. Revenue: per-consultation fee (B2C) + corporate/insurance health plans (B2B). COVID drove adoption; retention requires building a habit. Key challenge: regulatory clarity on prescribing via teleconsultation is evolving.
Teleconsultation requires understanding of clinical workflows, doctor psychology, and patient trust-building — rare combination with tech product skills. Red flag: tech product candidates without clinical domain understanding for clinical ops roles.
🚫 Red Flags
⚠️ Generic tech product candidates without healthcare domain understanding for clinical product roles
⚠️ Growth marketing candidates without understanding of health information regulations (no misleading health claims)
⚠️ Clinical operations candidates without doctor network management experience
Business Model
Health InsurTech: digital-first health insurance distribution (aggregation + direct) and claims management. Revenue: commission on premiums (distribution) + claims processing fees. India's health insurance penetration is low (under 40% of population) — massive growth market. IRDAI regulation governs product design and distribution.
Health insurance tech requires understanding of both InsurTech and clinical claims. Actuarial talent for health insurance is extremely scarce. Red flag: general insurance candidates without health-specific underwriting and claims knowledge.
🚫 Red Flags
⚠️ General insurance candidates for health insurance roles without health-specific underwriting and clinical claims knowledge
⚠️ Technology candidates without insurance core systems knowledge (policy management, claims adjudication)
⚠️ Sales candidates without understanding of group health vs individual health insurance sales dynamics
Business Model
EHR/HIS software: hospital information systems, clinic management software, and the ABDM (Ayushman Bharat Digital Mission) health data infrastructure. Revenue: SaaS subscription (smaller hospitals/clinics) + enterprise implementation fees (large hospitals). ABDM mandates ABHA (health ID) integration.
EMR/HIS requires both healthcare domain knowledge and SaaS product skills. ABDM creates a new compliance and integration layer. Red flag: generic SaaS product candidates for healthcare HIS roles without clinical workflow understanding.
🚫 Red Flags
⚠️ Generic SaaS product managers without clinical workflow understanding for EMR product roles
⚠️ Sales candidates without hospital C-suite relationship experience for enterprise HIS sales
⚠️ Implementation candidates without healthcare-specific change management experience (clinical staff resistance to new systems)
Business Model
Healthcare AI: AI/ML models for diagnostic imaging (radiology, pathology), early disease detection, drug discovery. Revenue: SaaS to hospitals (diagnostic AI) + royalty/licensing (drug discovery). India has produced globally recognised AI-in-health companies — Qure.ai and Niramai have international customers.
Key India Companies
Qure.ai (radiology AI)
Niramai (breast cancer AI)
Tricog Health (cardiac AI)
SigTuple (pathology AI)
Wellthy Therapeutics (chronic disease AI)
Innoplexus (drug discovery AI)
Aindra Systems (cervical cancer screening)
Org Structure Signals
Data Science / AI Engineering, Clinical Validation, Regulatory (FDA/CE for SaMD), Sales (hospital procurement), Product.
Hot Roles SNH Recruits
Head of AI/ML (Healthcare)
Clinical Affairs Head (AI Validation)
Regulatory Affairs Head (SaMD — FDA/CE)
Product Head (Diagnostic AI)
Data Science Lead
Hospital Sales Head (AI Solutions)
🔍 Recruiter Intelligence
Healthcare AI requires the rarest combination: clinical domain knowledge + AI/ML technical depth + regulatory understanding for Software as a Medical Device (SaMD). Red flag: generic AI engineers without clinical domain understanding for clinical AI product roles.
🚫 Red Flags
⚠️ Generic AI/ML engineers without clinical domain knowledge or medical data familiarity
⚠️ Clinical candidates without comfort with AI system validation and bias assessment
⚠️ Regulatory candidates without SaMD (Software as a Medical Device) regulatory pathway knowledge (FDA 510k for software)
Business Model
Connected health monitoring: continuous glucose monitors (CGM), remote patient monitoring (RPM) for chronic disease, ICU monitoring platforms. Revenue: device + subscription (data platform). Post-COVID, hospital at home and ICU monitoring have become viable businesses.
Connected health requires understanding of both IoT device constraints and clinical workflow integration. Red flag: consumer IoT candidates without clinical environment understanding for hospital-facing connected health products.
🚫 Red Flags
⚠️ Consumer IoT candidates without clinical workflow and hospital IT integration experience
⚠️ Clinical candidates without comfort with connected device data interpretation and remote monitoring protocols
⚠️ Sales candidates without C-suite hospital selling experience — connected health is a capital decision
Business Model
CROs run clinical trials on behalf of pharma/biotech companies. Revenue: per-trial fees (study management fees + patient visit fees). India CRO market: $2.5B+, growing 15%+ annually. India's advantages: large patient population, lower costs, English-speaking investigators.
CRO clinical operations requires GCP training and clinical trial monitoring experience. Red flag: hospital clinical staff for CRO clinical monitor roles without trial monitoring experience — site management and trial monitoring are different disciplines.
🚫 Red Flags
⚠️ Hospital clinical staff for CRO clinical monitor roles without formal GCP training and trial monitoring experience
⚠️ Business development candidates without pharma client relationship experience and clinical trial scope understanding
Business Model
Clinical trials: Phase I (safety, small group), Phase II (efficacy, larger group), Phase III (pivotal trial, large population), Phase IV (post-marketing). India has 200+ clinical trial sites. CDSCO approval required for all trials in India. India's trial costs are 50-60% lower than US/Europe.
Clinical trial sites require GCP-certified physicians (Principal Investigators) and trained coordinators. Red flag: general physicians for Principal Investigator roles without GCP certification and clinical trial conduct experience.
🚫 Red Flags
⚠️ General physicians for PI roles without GCP training and clinical trial experience
⚠️ Clinical data managers without familiarity with EDC (Electronic Data Capture) systems (Medidata Rave, Oracle InForm)
⚠️ Ethics committee coordinators without regulatory knowledge of ICMR guidelines and CDSCO Schedule Y requirements
Business Model
Regulatory affairs: compiling and filing documentation to receive marketing approval from health authorities. CDSCO (India), US FDA (USA), EMA (Europe), WHO are the key regulators. Each market requires different dossier format (CTD format for most). Drug approval timelines: 6 months (CDSCO fast track) to 4 years (FDA NDA).
Regulatory affairs is market-specific — USFDA, EMA, and CDSCO expertise are distinct. Thin talent pool for experienced US FDA regulatory experts in India. Red flag: CDSCO-only regulatory candidates for US FDA ANDA-filing roles without CTD dossier preparation experience.
🚫 Red Flags
⚠️ CDSCO regulatory candidates for USFDA roles without CTD format and ANDA preparation experience
⚠️ Device regulatory candidates for drug regulatory roles without understanding of pharma-specific submission requirements
⚠️ Regulatory candidates without experience managing regulatory queries and information requests from agencies
Business Model
Pharmacovigilance (PV): monitoring, detecting, assessing, and preventing adverse effects of marketed drugs. Mandatory for all drug marketing authorisations (CDSCO requires PV centre setup). Revenue: PV outsourcing to CROs or pharma-owned PV centres. India has significant outsourced PV operations for global pharma.
Key India Companies
Sun Pharma (PV centre)
Cognizant (PV outsourcing)
Accenture Life Sciences (PV)
Icon (PV)
IQVIA India (PV)
Dr. Reddy's PV
Parexel PV
Wipro Life Sciences (PV)
Org Structure Signals
Medical Safety Officers, PV Analysts, Signal Detection, Aggregate Report writers, PV Quality, Regulatory (PSUR submission).
Hot Roles SNH Recruits
Pharmacovigilance Head
Medical Safety Officer (MD required for serious AEs)
PV Analyst / Associate
Signal Detection Head
Aggregate Report Writer (PSUR/PBRER)
PV Quality Head
🔍 Recruiter Intelligence
PV requires ICH E2 guideline knowledge and medical background for serious adverse event assessment. Red flag: clinical research (CRA) candidates for medical safety officer roles without adverse event medical assessment experience.
🚫 Red Flags
⚠️ CRA/clinical operations candidates for Medical Safety Officer roles requiring medical degree and adverse event assessment capability
⚠️ PV analysts without MedDRA coding knowledge and ICH E2 guidelines familiarity
⚠️ Aggregate report writers without PSUR/PBRER structure knowledge and authoring experience
Business Model
Medical affairs: engaging healthcare professionals (HCPs) with scientific evidence about drug products. MSLs (Medical Science Liaisons) build peer-to-peer scientific relationships with Key Opinion Leaders (KOLs). Revenue-indirect: medical affairs supports commercial by building scientific credibility and physician confidence.
Key India Companies
All large pharma companies have MA departments
Johnson & Johnson India
Roche India
Novartis India
AstraZeneca India
Pfizer India
Abbott India
Sanofi India
Org Structure Signals
Medical Affairs (MSL, Medical Managers), Medical Information, Health Economics & Outcomes Research (HEOR), Publication Planning, Medical Education.
Hot Roles SNH Recruits
Medical Science Liaison (MSL)
Medical Manager
Head of Medical Affairs
Head of HEOR
Medical Information Manager
Medical Education Manager
🔍 Recruiter Intelligence
MSL is a unique profile requiring medical/scientific training (MD, PharmD, or PhD) combined with communication skills for peer-to-peer KOL engagement. Red flag: pharma sales candidates for MSL roles without postgraduate medical or pharmacy qualification.
🚫 Red Flags
⚠️ Pharma sales candidates for MSL roles without medical/scientific postgraduate qualification (MD, PharmD, PhD is minimum)
⚠️ MSL candidates from one therapy area assuming transferability to another without therapy area calibration
⚠️ HEOR candidates without health economics modelling and outcomes research methodology experience
The Landscape
India's Pharma & Healthcare Economy
Scale, regulation, talent archetypes, and the pharma-to-health migration.
India's Pharma & Healthcare Landscape
India's healthcare economy is ₹25L Cr+ and growing at 12% CAGR. Pharma is the largest sub-sector (India is the pharmacy of the world); hospitals and diagnostics are the fastest-growing.
🏶️ India's Pharma Strengths
Generic drugsIndia supplies 20% of global generic drugs by volume
Vaccine manufacturingSerum Institute is the world's largest vaccine manufacturer
API productionIndia produces 57% of world's generic APIs
CRO destinationIndia is the world's preferred clinical trial location
🏭 Key Regulations
CDSCOCentral Drugs Standard Control Organisation — India's FDA equivalent
Schedule MGMP requirements for pharma manufacturing in India
ABDMAyushman Bharat Digital Mission — digital health data infrastructure
ICMR guidelinesIndian Council of Medical Research — clinical research governance
The Pharma/Health Talent Archetypes
Commercial Track (MR → NSM)
Medical Representative → Area Manager → Regional Sales Manager → Zonal Manager → National Sales Manager → VP Sales. India's largest pharma career path. High volume, target-driven, prescription-focused.
Medical Affairs Track (MSL)
Medical Science Liaison → Senior MSL → Medical Manager → Head of Medical Affairs. Requires medical/PhD qualification. Scientific engagement, not selling. KOL relationship building.
Technical Track (Manufacturing, QA, RA)
Plant roles, quality systems, regulatory filings. Stable, technical, qualification-driven. US FDA regulatory experts are the scarcest and highest-paid in this track.
Hiring Intelligence
Hardest Roles & Screening Questions
Where the talent pool is thinnest — and the questions that reveal real pharma & healthcare expertise.
Hardest Pharma & Healthcare Roles to Fill
US FDA Regulatory Affairs Head
ANDA filing + FDA inspection management + Warning Letter response experience. Less than 500 people in India have all three. Globally competed and expensive.
Medical Science Liaison (MSL) — Specialty
Oncology, neurology, cardiology MSLs require specialist MD degree AND MSL experience. Very thin pool in emerging specialties.
GCP-Trained CRO Clinical Operations
Senior CRAs and Clinical Project Managers with multi-country trial management experience are globally competed — US, EU, and India CROs all fish from the same small pool.
ABDM Integration Architect
Bridging healthcare domain with ABDM technical standards. Extremely rare combination of clinical workflow knowledge and digital health interoperability expertise.
Health AI PM (SaMD regulatory)
Product manager for AI diagnostic tools needs: ML product understanding + clinical domain + SaMD regulatory pathway (FDA 510k for software). Almost non-existent as a pre-built profile.
Hospital CEO (Multi-Specialty)
Running a large hospital requires: clinical governance, financial sustainability, regulatory compliance, and patient experience — simultaneously. True hospital CEO talent pool is tiny.
Screening Questions by Track
For pharma commercial leaders
"What was your prescription market share in your top therapy area, and what was the specific strategy that moved it?" Tests: commercial depth vs. activity management.
For regulatory affairs candidates
"Walk me through the most complex query you received from a regulatory agency — what did they ask, how did you research the response, and what was the outcome?"
For hospital operations candidates
"What was the ARPOB (Average Revenue Per Operational Bed) in your hospital, and what did you do to improve it?" Tests: hospital financial literacy.
For MSL candidates
"Tell me about a KOL relationship you built from scratch — how did you get the first meeting, what scientific value did you provide, and how did it evolve?"
Role Deep Dives
Pharma Sub-Sector Talent Differences
What travels between sub-sectors — and what doesn't. The portability map for pharma & healthcare talent.
Pharma Sub-Sector Talent Differences
🌈 Branded Generic Pharma (India market)
Sales modelMR promotes to doctors; doctor prescribes brand to patient
Key talentMR, RSM, NSM, Medical Affairs, Brand Management
Success metricPrescription market share, doctor coverage
TransferabilityHigh within India pharma; moderate to FMCG OTC
🏠 Generic Export Pharma (US/EU)
Sales modelANDA approved → supply to US wholesalers; price is the lever
Success metricANDA approvals, first-to-file, market share per molecule
TransferabilityLow — FDA expertise is highly specific
Hospital vs Pharma vs HealthTech — Talent Portability
High Portability
Medical Affairs/MSL — moves between therapy areas with calibration Healthcare Finance — hospital finance to pharma finance (different metrics, same discipline) Digital health PM — moves across healthtech sectors
Medium Portability
Hospital ops → HealthTech: healthcare ops understanding transfers, tech context needs building Pharma commercial → OTC/Consumer Health: prescription to OTC is a significant shift
Low Portability
US FDA regulatory — market-specific, not transferable Clinical trial operations — CRO to pharma yes; pharma to CRO challenging MSL therapy area expertise — oncology MSL ≠ neurology MSL without retraining
Compensation
Pharma & Healthcare Pay — India 2024-25
MR to NSM, MSL to Head of Medical Affairs, hospital CEO — benchmarks by role and seniority.
Pharma & Healthcare Compensation — India 2024-25
Total CTC in ₹ Lakhs per annum. Significant variation by company tier (MNC vs Indian), specialty, and track.
Pharma Commercial Track
Medical Representative: ₹3-8L (+ incentives)
RSM (8-12 yrs): ₹15-35L
NSM / VP Sales: ₹40-100L
MNC pharma pays 20-30% premium over Indian pharma
Medical Affairs / MSL
MSL (3-6 yrs): ₹12-25L
Senior MSL / Medical Manager: ₹22-50L
Head of Medical Affairs: ₹60-120L
Specialty MSL (oncology, neurology): premium
Regulatory Affairs
RA Manager (5-8 yrs): ₹12-28L
Head of RA (India market): ₹30-65L
Head of RA (USFDA): ₹55-120L
US FDA expertise commands significant premium
Hospital Operations
Hospital GM / COO: ₹25-80L
Hospital CEO (mid-size): ₹60-150L
Hospital CEO (large chain): ₹120-300L
Location (metro vs tier 2) has significant impact
Pharma Manufacturing
Plant Head (Schedule M): ₹25-60L
Plant Head (US FDA): ₹50-100L
VP Manufacturing: ₹90-200L
FDA-approved plant heads: significant premium
CRO / Clinical Research
Clinical Research Associate (CRA): ₹5-15L
Clinical Project Manager: ₹18-40L
Head of Clinical Operations: ₹50-100L
Global CRO pays premium over Indian CRO
Practitioner Lab
Scenarios & Jargon Decoder
Six real scenarios with recommended moves — plus the pharma & healthcare jargon every SNH recruiter must know.
Practitioner Lab — Pharma & Healthcare Scenarios
Scenario 1: MR for MSL Role
Pharma client hiring MSL for Oncology. Strong candidate — 10 years as RSM in oncology, excellent KOL relationships, knows all the oncology doctors. No postgraduate scientific qualification (only BSc Pharmacy + MBA).
The move: MSL is a peer-to-peer scientific engagement role — doctors respect an MSL because they hold a medical or doctoral qualification. An RSM relationship is commercial; an MSL relationship is scientific. Be direct with the client: "This person has excellent commercial oncology relationships but lacks the scientific credibility that oncologists require from an MSL. Would you consider a Medical Manager role instead?"
Scenario 2: The ANDA Filing Gap
US-export pharma company hiring Head of Regulatory Affairs. Strong candidate — 15 years in CDSCO regulatory (Schedule M, clinical trial approvals in India). No ANDA filing experience.
The move: CDSCO and USFDA regulatory are different disciplines. ANDA filing requires CTD (Common Technical Document) format knowledge, eCTD submission systems, and FDA reviewer interaction experience that CDSCO-only candidates don't have. Present honestly: "This profile is excellent for CDSCO/India regulatory but would need 12-18 months to become self-sufficient on ANDA filings."
Scenario 3: Hospital CEO from Hospitality
Large hospital chain hiring CEO for a new 300-bed hospital. Strong candidate — 20 years in hotel management (Taj, ITC), currently GM of a 5-star hotel. Impressive operations credentials but zero healthcare experience.
The move: Hospitality operations and hospital operations share service culture but differ in clinical governance, regulatory compliance (NABH), and patient safety. A hospital CEO must understand clinical protocols, infection control, and medical staff credentialing. This is a high-risk hire. Present the trade-off clearly and suggest a Medical Director/COO structure alongside this CEO if the client insists.
Scenario 4: HealthTech PM Without Clinical Domain
HealthTech startup (AI diagnostic platform for radiology) hiring Head of Product. Strong candidate — 8 years PM at a consumer tech company, excellent data product skills, no healthcare experience.
The move: AI diagnostic products are Software as a Medical Device (SaMD) — regulatory requirements, clinical validation, and radiologist workflow integration are non-negotiable. A consumer tech PM without clinical domain will build the wrong product. Probe: "How would you design a clinical validation study for this AI? What's a Type I vs Type II error in a diagnostic context?" If they can't answer, the domain gap is real.
Scenario 5: Pharma Quality for Medical Devices
Medical device startup (Class III implants) hiring QA Head. Best candidate: 12 years QA in pharma (GMP, Schedule M, USFDA), no medical device experience.
The move: Pharma GMP and medical device ISO 13485 are related but different quality systems. Device QMS requires design controls, V&V testing, risk management (ISO 14971), and post-market surveillance that pharma QA doesn't cover. Probe: "Tell me about your experience with design history files and FMEA for device development." If blank, the transition requires significant learning. Present the risk clearly.
Scenario 6: The Pharmacovigilance Scale-Up
Global pharma company setting up PV centre in India for cost arbitrage. Hiring PV Head to build a team of 50 PV associates in 6 months. Budget: ₹60-80L for the head. You can't find candidates with both PV technical depth AND large team build experience.
The move: Split the brief. The PV technical head (deep in ICH E2, MedDRA, PSUR) is a ₹60L profile. The operations build (50-person team, training programmes, SLA governance) is a different capability. Suggest: hire a technically deep PV Head + a strong PV Operations Manager. Both together cost less than the mistake of a wrong hire for this build.
Pharma & Healthcare Jargon Decoded
ANDA
Abbreviated New Drug Application — the filing submitted to US FDA for approval to market a generic drug in the USA. Filing ANDA requires CTD format dossier, bioequivalence study, and chemistry/manufacturing data.
GMP (Good Manufacturing Practice)
Manufacturing quality standards for pharma. Schedule M = India GMP; WHO GMP = export markets; 21 CFR = US FDA GMP. Each has different requirements — US FDA is the most stringent.
GCP (Good Clinical Practice)
International standard for clinical trial conduct. ICH E6 guideline. All CRAs, PIs, and CTCs must be GCP-certified. GCP certification is mandatory — it's not optional for anyone involved in clinical trials.
ABDM (Ayushman Bharat Digital Mission)
India's digital health infrastructure: ABHA (health ID), PHR (Personal Health Records), ABDM gateway for health data interoperability. All digital health platforms must integrate with ABDM.
MSL vs KAM
Medical Science Liaison = scientific peer relationship with KOLs (Key Opinion Leaders / senior doctors). Key Account Manager = commercial relationship with hospital purchasing committees. MSL needs medical degree; KAM needs sales skills. Do not confuse these roles.
ARPOB
Average Revenue Per Operational Bed — key hospital financial metric. Revenue ÷ Number of operational beds. A benchmark metric for hospital CEO and CFO candidates. If a hospital operations candidate doesn't know their ARPOB, probe further.